Epidemiology of drug-resistant epilepsies;Epidémiologie des épilepsies partielles pharmaco- résistantes

Revue Neurologique

Volumn 160, Issue 5 SUPPL., 2004, Pages

  Jallon, P ^a,b  

^a Eustachian Tube Disorders Center   (Switzerland)

^b U d'EEG et d'Epileptologie Clinique   (Switzerland)

Author keywords

Drug resistant epilepsies; Epidemiology; Epilepsy; Risk factors; Surgery

Indexed keywords

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ANTIEPILEPTIC DRUG RESISTANCE; CHILD; CONFERENCE PAPER; DRUG RESISTANT EPILEPSY; DRUG RESISTANT PARTIAL EPILEPSY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FOCAL EPILEPSY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEUROSURGERY; ONSET AGE; PREVALENCE; PROGNOSIS; RISK FACTOR; SEIZURE; DRUG RESISTANCE; FRANCE; NOMENCLATURE; RECURRENT DISEASE; REVIEW; AGED; FEMALE; HEALTH; INFANT; MALE; CLINICAL TRIAL; GEOGRAPHIC DISTRIBUTION; META ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW;

ANTICONVULSIVE AGENT;

ADULT; ANTICONVULSANTS; CHILD; DRUG RESISTANCE; EPILEPSIES, PARTIAL; FRANCE; HUMANS; INCIDENCE; PREVALENCE; RECURRENCE; TERMINOLOGY; AGED; FEMALE; INFANT; MALE; WORLD HEALTH;

EID: 4544287732     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (97)

1. AIKIÄ M, KÄLVIÄINEN R, MERVAALA E, et al. (1999). Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor. Epilepsy Res, 37: 159-167.
2. ANNEGERS JF, HAUSER WA, ELVEBACK LR. (1979). Remission of seizures and relapse in patients with epilepsy. Epilepsia, 20; 729-737.
3. ANNEGERS JF, HAUSER WA, LEE JR-J, ROCCA WA. (1995). Secular trends and birth cohort effects in unprovoked seizures: Rochester, Minnesota, 1935-1984. Epilepsia, 36: 575-576.
4. ARROYO S, BRODIE MJ, AVANZIN; G, et al. (2002). Is refractory epilepsy preventable? Epilepsia, 43: 437-444.
5. ARTS WFM, GEERTS AT, BROUWER OF, BOUDEWYN P, STROINK H, VAN DONSELAAR CA. (1999). The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia, 40: 726-734.
6. ARTS W FM. (2003). The Dutch study of epilepsy in childhood. In Jallon P., Berg A., Dulac O., Hauser A. (eds), Prognosis of epilepsies. pp.135-146, John Libbey, Montrouge.
7. BEGHI E, TOGNONI G. (1988). Prognosis of epilepsy in newly referred patients: a multicenter prospective study. Collaborative group for the study of epilepsy. Epilepsia, 29: 236-243.
8. BERG AT, LEVY SR, NOVOTNY EJ, et al. (1996). Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia, 37:24-30.
9. BERG AT, SHINNAR S, LEVY SR, TESTA FM. (1999). Newly diagnosed epilepsy in children presentation at diagnosis. Epilepsia, 40: 445-452.
10. BERG AT, SHINNAR S, LEVY SR, et al. (2001). Defining early seizure outcomes in pediatric epilepsy: the good, the bad and the in-between. Epilepsy Res, 43: 75-84.
11. BERG AT, SHINNAR S, LEVY SR, TESTA F, SMITH-RAPAPORT S, BECKERMAN B. (2001b). Intractable epilepsy in children: a prospective study. Neurology, 56: 1445-1452.
12. BERG A, VICKREY BG, LANGFITT JT, et al. (2003 a). How long does it take for epilepsy to become intractable? Neurology, 60: 186-190.
13. BERG A, VICKREY BG., LANGFITT JT, et al. (2003b). The multicenter study of epilepsy surgery: recruitment and selection for surgery. Epilepsia, 44: 1425-1433.
14. BOUMA PAD, PETERS ACB, ARTS RJHM, et al. (1987). Discontinuation of antiepileptic therapy: a prospective study in children. J Neurol Neurosurg Psychiatry, 50: 1579-1583.
15. BRAATHEN G, ANDERSSON T, GYLJE H, et al. (1996). Comparison between one and three years of treatment in uncomplicated epilepsy. A prospective study. I. Outcome in different seizures types. Epilepsia, 37: 822-32.
16. BRODIE MJ. (2001). Management strategies for refractory localization related seizures. Epilepsia, 42: 27-30.
17. BRODIE MJ, KWAN P. (2002). Staged approach to epilepsy management. Neurology, 58: S2-S8.
18. BRORSON LO, WRANNE L. (1987). Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia, 28: 324-330.
19. CALLAGHAN N, GANETT A, GOGGIN T.(1988). Withdrawal of anticonvulsant drugs in patients free of seizures for two years. N Engl J Med, 318:942-946.
20. CAMFIELD PR., CAMFIELD C. (1996). Antiepileptic drug therapy: when is epilepsy truly intractable? Epilepsia, 37: S60-S65.
21. CAMFIELD PR, CAMFIELD CS, GORDON K, DOOLEY JM. (1997). If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug? J Pediatr, 131: 821-824.
22. CAMFIELD P, CAMFIELD C. (2003). Nova Scotia pediatric epilepsy study. In: Jallon P, Berg A, Dulac O, Hauser A. (eds), Prognosis of epilepsies, pp.135-146, John Libbey, Montrouge
23. CASETTA I, GRANIERI E, MONETTI VC, et al. (1999). Early predictors of intractability in childhood epilepsy: a community-based case-control study in Copparo Italy. Acta Neurol Scand, 99: 329-333.
24. CHADWICK DW. (1995). Do anticonvulsants alter the natural course of epilepsy? Case for early treatment is not established. BMJ, 310: 177-188.
25. CLELAND PG, MOSQUERA I, STEHART WP, FOSTER JB. (1981). Prognosis of isolated seizure in adult-life. BMJ, 283:1364.
26. COCKERELL OC, JOHNSON AL, SANDER JW, et al. (1995). Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet, 346: 140-4.
27. COCKERELL OC, ECKLE I, GOODRIDGE DMG, SANDER JWAS, SHORVON SD. (1997). Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia, 38: 31-46.
28. COLLABORATIVE GROUP FOR THE STUDY OF EPILEPSY. (1992). Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Epilepsia, 33: 45-51.
29. CRAWFORD PM. (2000). Epidemiology of intractable focal epilepsy. In: Intractable Focal Epilepsies. Oxbury J, Polkey C, Duchowny M. (edit). W.B.Saunders. Edinburgh.
30. Devinsky O. (1999). Patients with refractory seizures. N Engl J Med, 334: 1565-1570.
31. DIOP AG, SENÉ-DIOUF F, BOISSY L, PREUX PM, NDIAYE IP. (2003). Prognosis of epilepsy in Africa. In Jallon P, Berg A, Dulac O, Hauser A. (eds), Prognosis of epilepsies, pp. 135-146, John Libbey Montrouge.
32. DLUGOS D, SAMMEL M. STROM B, FARRAR J. (2001). Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology, 57: 2259-2264.
33. ELWES RDC, JOHNSON AL, SHORVON SD, REYNOLDS EH. (1984). The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med, 311: 944-947.
34. ELWES RDC, JOHNSON AL, REYNOLDS EH. (1988). The course of untreated epilepsy. BMJ, 297: 948-950.
35. EMERSON R. D'SouZA BJ, VINING EP, HOLDEN KR, MELLITS ED, FREEMAN JM. (1981). Stopping medication in children with epilepsy. N Engl J Med, 304: 1125-1129.
36. ENGEL J. (1997). Update on the surgical treatment of the epilepsies. Neurology, 43: 1612-7.
37. FORSGREN L. (1995). Epidemiology of intractable epilepsy in adults In: Intractable epilepsy Johannessen SI, Gram L, Sillanpaa M, Tomson T, editors. Pertersfield: Wrightson Biomedical Publishing Ltd, 25-40.
38. FORSGREN L (2003). Prognosis of epilepsy based on epidemiological studies from Vasterbotten, Northern Sweden. In Jallon P, Berg A, Dulac O, Hauser A. (eds), Prognosis of epilepsies. pp.135-146, John Libbey Montrouge.
39. FRENCH JA, WILLIAMSON PD, THADANI VM, et al. (1993). Characteristics of medial temporal lobe epilepsy: I: results of history and physical examination. Ann Neurol, 34: 74-780.
40. GOODRIDGE DMG, SHORVON SD. (1983). Epilepsy in a population 6000. Br Med J, 287: 641-647.
41. HART YM, SHORVON SD. (1985). The nature of epilepsy in the general population: I, characteristics of patients receiving medication for epilepsy. Epilepsy Res, 21: 43-9.
42. HAUSER WA. (1992). The natural history of drug resistant epilepsy: epidemiologic considerations. Surgical treatment of epilepsy. Epilepsy Res, 5: 25-28.
43. HAUSER WA, ANNEGERS JF, KURLAND LT. (1993). The incidence of epilepsy and unprovoked seizures in Rochester, Minnesota. Epilepsia, 34: 453-468.
44. HERMANS G, NOACHTAR S, TUXHORN I, HOLTAUSEN H, EBNER A, WOLF P. (1996). Systematic testing of medical intractability for carbamazepine, phenytoin and phenobarbital or primidone in monotherapy in patients considered for epilepsy surgery. Epilepsia, 37: 675-679.
45. HOLMES GL, ENGEL J. (2001). Predicting medical intractability of epilepsy in children: how certain can we be? Neurology, 56: 1430-1431.
46. HOLOWACH J, THURSTON DL, HIXON BB, KELLER AJ. (1982). Prognosis of childhood epilepsy. Additional follow-up of 148 children, from 15 to 23 years, after withdrawal of anticonvulsivant therapy. N Engl J Med, 306:831-836.
47. KERANEN T, RIEKKINEN R (1988). Severe epilepsy: diagnostic and epidemiological aspects. Acta neurologica Scand, 78: 7-14.
48. JALLON P, DESPLAND R (1996). Les epilepsies pharmaco-résistantes: épidémiologie et facteurs de risque. Med et Hyg, 54: 1784-1786.
49. JALLON P. (1997). The problem of intractability: the continuing need for new medical therapies in epilepsy. Epilepsia, 38: S37-S42.
50. JALLON P. (1999) Epidemiology of epilepsies. Handbook of Clinical Neurology. H. Meinardi, editor. Vol. 72: The Epilepsies, Part I.
51. JALLON P. (1997a). Epilepsy in developping countries. ILAE workshop of the Commission of epilepsy in developping countries. Epilepsia, 38: 1143-1151.
52. JALLON R (1997b). The problem of intractability: the continuing need for new medical therapies in epilepsy. Epilepsie, 9: 37-42.
53. JALLON P, LOISEAU P, LOISEAU J. ON BEHALF OF GROUPE CAROLE (coordination Active du Reseau Observatoire de l'Epilepsie). (2001). Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsie, 42: 464-475.
54. JALLON P, LANDRY S.(2003). Long term of first epileptic seizures. EPIGEN study. In Jallon P, Berg A, Dulac O, Hauser A. (eds). Prognosis of epilepsies, pp.135-146, John Libbey, Montrouge.
55. JALLON P. (2004). Mortality in patients with epilepsy. Current Opinion in Neurology. A paraître.
56. JUUL-JENSEN R (1964). Frequency of recurrence after discontinuance of anti-convulsant therapy in patients with epileptic seizures. Epilepsia, 5: 325-363.
57. JUUL-JENSEN P. (1968). Frequency of recurrence after discontinuance of anti-convulsant therapy in patients with epileptic seizures. A new follow-up study after 5 years. Epilepsia, 9: 11-17.
58. JUUL-JENSEN P, FOLDSPANG A. (1983). Natural history of epileptic seizures. Epilepsia, 24: 297-312.
59. JUUL-JENSEN P (1986). .Epidemiology of intractable epilepsy. In: Intractable Epilepsy, Schmidt D, Morselli P eds. New-York: Raven Press 5-11.
60. KWAN P, BRODIE M.J. (2000). The early identification of refractory epilepsy. N. Eng. J Med, 342: 314-319.
61. KWAN P, BRODIE M.J. (2002). Refractory epilepsy: a progressive, intractable but preventable condition? Seizure, 11: 77-84.
62. Ko. T.S, HOLMES GL. (1999). EEG and clinical predictors of medically intractable childhood epilepsy. Clin Neurophysiol, 110: 1245.1251.
63. KERANEN T, RIEKKINEN PJ. (1993). Remission of seizures in untreated epilepsy. Br Med J, 307: 483.
64. LHATOO SD, SANDER JWAS, SHORVON SD. (2001). The dynamics of drug treatment in epilepsy, an observational study in an unselected population based cohort with newly diagnosed epilepsy followed prospectively over 11-14 years. J Neurol Neurosurg Psychiatry, 71:632-7.
65. LHATOO SD, SOLOMON JK, Mc EVOY AW, KITCHEN ND, SHORVON SD, SANDER JWAS. (2003). A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom. Epilepsia, 44: 673-676.
66. LINDSTEN H, STENLUD H., FORSGREN L. (2001). Remission of seizures in a population-based adult cohort with a newly diagnosed unprovoked epileptic seizure. Epilepsia, 1025-1030.
67. LOISEAU J, LOISEAU P, DUCHE B, GUYOT M, DARTIGUES J, AUBLET B. (1990). Survey of epileptic disorders in the French South West. Epilepsia, 37:391-396.
68. LOISEAU P, JALLON P. (1995). Epilepsies pharmaco-résistantes de l'adulte. Rev Neurol (Paris), 151: 295-306.
69. MAcDoNALD BK, JOHNSON AL, GOODRIDGE DM, COCKERELL OC, SANDER JWAS, SHORVON SD. (2000). Factors predicting prognosis of epilepsy after presentation of seizures. Ann Neurol, 48: 833-41.
70. MACDONALD B. (2001). The prognosis of epilepsy. Seizure, 10: 347-358.
71. MATRICARDI M, BRINCIOTTI M, BENEDETTI P. (1989). Outcome after discontinuation of antiepileptic drug therapy in children. Epilepsia, 30: 582-589.
72. MATTSON RH, CRAMER JA, COLLINS JF et al. (1985). Comparison of carbamazepine, phenobarbital, phenytoïn and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med, 313: 145-51.
73. MATTSON RH, CRAMER JA, COLLINS JF. (1996). and the Department of Veterans Affairs epilepsy Cooperative Studies No 118 and No 264 Group. Prognosis for total control of complex partial and secondary generalised tonic-clonic seizures. Neurology, 47: 68-76.
74. MRC ANTIEPILEPTIC DRUG WITHDRAWAL GROUP. (1991). Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet, 337: 1175-1180.
75. MEDICAL RESEARCH COUNCIL ANTIEPILEPTIC DRUG WITHDRAWAL STUDY GROUP. (1993). Pronostic index for recurrence after remission of epilepsy. BMJ, 306: 1374-1378.
76. MUSICCO M, BEGHI E, SOLARI A, et al. (1993). Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology, 43: 478-483.
77. MUSICCO M, BEGHI E, SOLARI A, VIANI F FOR THE FIRST GROUP. (1997). Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology, 49: 991-998.
78. NAKKEN KO. (1995). Medical risks in intractable epilepsy. In: Johannessen SI, Gram L, Sillanpaa M, et al., editors, Intractable epilepsy. Petersfield: Weightson Biomedical Publishing Ltd., 171-82.
79. O'DONOGHUE M., SANDER JWAS. (1996). Does early anti-epileptic drug treatment alter the prognosis for remission of the epilepsies. J R Soc Med, 89: 245-248.
80. OHTSUKA Y, YOSHINAGA H, KOBAYASHI K, MUFIAKAMI N, YAMATOGI Y, OKA, TSUDA T. (2001). Predictors and underlying causes of medically intractable localization-related epilepsy in childhood. Pediatr Neurol, 24: 209-213.
81. OKA E, ISHIDA S, OHTSUKA Y, OHTAHARA S. (1995). Neuroepidemiological study of childhood epilepsy by application on international classification of epilepsies and epileptic syndromes. Epilepsia, 36: 658-661.
82. OKUMA T, KUMASHIRO AND THE GROUP FOR THE STUDY OF PROGNOSIS OF EPILEPSY IN JAPAN. (1981). Natural history and prognosis of epilepsy: report of a multi-institutional study in Japan. Epilepsia, 22: 35-53.
83. OVERWEG J, ROWAN AJ, BINNIE CD et al. (1987). Clinical and EEG prediction of seizure recurrence following antiepileptic drug withdrawal. Epilepsy Res, 1: 272-283.
84. PALMINI A, ANDERMANN F, OLIVIER A. (1991). Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann Neurol, 30: 741-749.
85. PERUCCA E. (1998). Pharmacoresistance in epilepsy: how should it be defined? CNS Drugs, 10: 171-9.
86. REGESTA, G. AND TANGANELLI, P. (1999). Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res, 34: 109-122.
87. REYNOLDS EH. (1987). Early treatment and prognosis of epilepsy. Epilepsia, 28: 97-106.
88. RODIN EA. (1968). The prognosis of patients with epilepsy. Charles C, Thomas, Springfield, IL.
89. SANDER JWAS. (1993). Some Aspects of Prognosis in the Epilepsies: A Review. Epilepsia, 34: 1007-1016.
90. SHAFER SQ, HAUSER WA, ANNEGERS JF, KLASS DW. (1988). EEG and other early predictors of epilepsy remission: a community study. Epilepsia, 29: 590-600.
91. SEMAH F, PICOT M-C, ADAM C, et al. (1998). Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology, 51: 1256-62.
92. SHINNAR S, VINING EPG, MELLITS ED et al. (1985). Discontinuing anti-epileptic medication in children with epilepsy after two years without seizures. N Engl J Med, 313: 976-980.
93. SHORVON SD. (1996). The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia, 37: 1-3.
94. SILLANPÄÄ M. (1993). Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia, 34: 930-936.
95. SILLANPÄÄ M, JALAVA M, KALEVA O, SHINNAR S. (1998) Long-term prognosis of seizures with onset in childhood. N Engl J Med, 338: 1715-1722.
96. SILLANPÄÄ M. (2003). Long term prognosis in Finnish childhood-onset epilepsy. In: Jallon P, Berg A, Dulac O, Hauser A. (eds), Prognosis of epilepsies. pp.135-146, John Libbey, Montrouge.
97. STEPHEN LJ, KWAN P, BRODIE MJ. (2001). Does the cause of localisation Related epilepsy influence the response to antiepileptic drug treatment? Epilepsia, 42: 357-362.